Companies: 48,686 Total Market Cap: 127339687136261.19

IDNA Genomics Public Ltd

CYS-IDNA

Medical Laboratories

Rank #24821

Market Cap 85.69 M

Volume 494.90

Price 31.04

Change (%) 0.00%

Country or region

Cyprus

IDNA Genomics Public Ltd's latest marketcap:

85.69 M

As of May 9, 2025, IDNA Genomics Public Ltd's market capitalization has reached $85.69 M. According to our data, IDNA Genomics Public Ltd is the 24821th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	85.69 M
Revenue (ttm)	0
Net Income (ttm)	0
Shares Out	2.76 M
EPS (ttm)	0
Forward PE	0.00
Ex-Dividend Date	n/a
Earnings Date	n/a

Market Cap Chart

Data Updated: May 9, 2025

IDNA Genomics Public Ltd's yearly market capitalization.

IDNA Genomics Public Ltd has seen its market value grow from €70.72 M to €76.19 M since 2022, representing a total increase of 7.73% and an annual compound growth rate (CAGR) of 3.06%.

Date	Market Cap	Change (%)
May 9, 2025	€76.19 M	0%
December 30, 2024	€76.19 M	0%
December 29, 2023	€76.19 M	7.73%
November 18, 2022	€70.72 M

Company Profile

About IDNA Genomics Public Ltd

IDNA Genomics Public Ltd is a biotechnology company specializing in genomics and personalized health care solutions. Founded in 2020 and headquartered in Nicosia, Cyprus, the company focuses on innovative genetic testing and pharmaceutical development.

Core Business Activities

Development and provision of advanced genetic tests in the field of genomics.
Research, development, and marketing of pharmaceutical products.

Company Overview

With a commitment to advancing personalized medicine, IDNA Genomics leverages cutting-edge biotechnology to improve health outcomes through tailored genetic insights and therapeutic solutions.

Frequently Asked Questions

As of May 9, 2025, IDNA Genomics Public Ltd (including the parent company, if applicable) has an estimated market capitalization of $85.69 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

IDNA Genomics Public Ltd global market capitalization ranking is approximately 24821 as of May 9, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Cyprus
Founded	2020
IPO Date	n/a
Employees	n/a
CEO
Sector
Industry	Medical Laboratories
Address	Ellinas House Nicosia, 1055 Cyprus